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Abstract
Any damage to the brain may affect cognition. However, although the effects of vascular changes have been
known for years, involvement of such changes is becoming increasingly better recognized. In particular the effects
of comorbid vascular disease to primary neurodegenerative processes adds to the complexity of the issue. An
attempt to clarify the problems needed specific attention to different points, which led to Consensus Reports on
several of them.
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Editorial
The ever-increasing global healthcare burden of dementia
[1] has changed considerably over the past decades.
Although Alzheimer’s disease (AD) is still considered the
most common disorder, it’s nosological entity is undergo-
ing constant revision. This is owing to the recognition that
the underlying brain pathology in most if not all elderly
people is complex and includes widespread vascular
changes, as well as deposition of TDP-43 and other abnor-
mal constituents. Vascular dementia (VaD) was previously
considered the second most common type of dementia,
but has been superseded by two other disorders, fronto-
temporal dementia and Lewy body disease.
Of these four disorders, most attention and efforts have
been devoted to AD, alas so far without impressive thera-
peutic results [2]. Therapies for the neurodegenerative
diseases frontotemporal dementia and Lewy body disease
have also not yet been determined, nor is a breakthrough
evident. However, vascular damage to the brain has a clear
pathogenesis and thus makes a much more likely thera-
peutic target.
Vascular cognitive impairment (VCI) is a blanket term
that covers a wide spectrum of disorders. They range in
intensity from mild cognitive impairment to full-blown
dementia, and in presentation from acute cortical strokes
to subcortical lesions, either lacunes or white matter disease
(or both in combination). Their pathogenesis can range
from vascular occlusions to hemorrhages, and their cause
can be genetic (such as cerebral autosomal-dominant arter-
iopathy with subcortical infarcts and leukoencephalopathy,
CADASIL), atherosclerotic, embolic, hypoperfusion, and
others.
The International Congress of Vascular Dementia
(ICVD) is a biannual convention that began in 1999 and
was last held in Ljubljana, Slovenia, in October 2015.
During this meeting, several teams of experts, coming
from different backgrounds and geographical origins,
were formed to tackle problems in the diagnosis and
treatment of vascular dementia. Their aim was to pro-
duce consensus statements on some of the contentious
topics within the field. Some of these teams have now
been successful in formulating conclusions, which are
now published in BMC Medicine [3–6].
Clinical diagnostic criteria for VCI are still not satisfac-
tory. An attempt to clarify the confusion and delineate
future solutions to existing needs was made by Perneczky
et al. [3]. Modern neuroimaging techniques using mag-
netic resonance imaging (MRI) are very sensitive for
showing white matter changes, lacunes, and microbleeds,
and their contribution is discussed by Heiss et al. [4].
In many disorders, autopsy is the gold standard for
diagnosis. However, in cognitive disorders there are
several impediments to a dependence on pathology. One
important problem is the heterogeneity of the brain
lesions, mentioned above. Another is the wide spectrum
of neuropsychological manifestations. But perhaps most
problematic is the fact that pathologists can diagnose
that the brain has been damaged by vascular lesions, but
cannot determine the clinical correlate. Thus, people
with the same extent of apparent brain damage may
have different cognitive manifestations. Moreover, the
additional damage imposed by other pathologies, suchCorrespondence: amoskor@tau.ac.il
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as the common co-occurrence of AD pathology [7],
complicates the interpretation of the pathological find-
ings. An attempt to deal with these issues and suggest
solutions has been made by McAleese et al. [5].
White matter disease of the brain is commonly seen in
elderly people and is commonly caused by small vessel
disease. However, the clinical manifestations of these
changes are again heterogeneous. In some cases, patients
may exhibit VCI up to severe dementia, which may be
termed Binswanger’s disease, others may have gait prob-
lems or vascular parkinsonism [8], while still others
develop depression. The entity of vascular depression is
the topic of a consensus statement by Aizenstein et al. [6].
These articles are an important contribution to the
existing literature. Surely further additions will appear in
the following months, and even more after the tenth
ICVD congress, scheduled to take place in Gdansk,
Poland, on 12–14 May 2017 (www.ICVD2017.pl).
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